Does Dopamine Replacement Medication Affect Postural Sequence Learning in Parkinson's Disease?

被引:13
|
作者
Hayes, Heather Anne [1 ]
Hunsaker, Nikelle [1 ]
Schaefer, Sydney Y. [4 ]
Shultz, Barry [2 ]
Schenkenberg, Thomas [3 ]
Boyd, Lara A. [5 ]
White, Andrea T. [2 ]
Foreman, Kenneth B. [1 ]
Dyer, Philip [6 ]
Maletsky, Rebecca [7 ]
Dibble, Leland E. [1 ]
机构
[1] Univ Utah, Dept Phys Therapy, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Exercise & Sport Sci, Salt Lake City, UT USA
[3] Univ Utah, Dept Neurol, Salt Lake City, UT USA
[4] Utah State Univ, Dept Hlth Phys Educ & Recreat, Logan, UT 84322 USA
[5] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada
[6] Brookhaven Natl Lab, Upton, NY 11973 USA
[7] Univ Kansas, Med Ctr, Landon Ctr Aging, Kansas City, KS 66103 USA
关键词
implicit sequence-specific learning; aging; acquisition; retention; CHALLENGE POINT; BASAL GANGLIA; IMPLICIT; PALLIDOTOMY; BALANCE; PERFORMANCE; HYPOTHESIS; FEATURES; SLEEP; TASK;
D O I
10.1123/mc.2014-0039
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Deficits in sequence-specific learning (SSL) may be a product of Parkinson's disease (PD) but this deficit could also be related to dopamine replacement. The purpose of this study was to determine whether dopamine replacement affected acquisition and retention of a standing Continuous Tracking Task in individuals with PD. SSL (difference between random/repeated Root Mean Square Error across trials) was calculated over 2 days of practice and 1 day of retention for 4 groups; 10 healthy young (HY), 10 healthy elders, 10 individuals with PD on, 9 individuals with PD off their usual dosage of dopamine replacement. Improvements in acquisition were observed for all groups; however, only the HY demonstrated retention. Therefore, age appeared to have the largest effect on SSL with no significant effect of medication. Additional research is needed to understand the influence of factors such as practice amount, task difficulty, and dopamine replacement status on SSL deficits during postural tasks.
引用
收藏
页码:325 / 340
页数:16
相关论文
共 50 条
  • [41] Hypomania and mania related to dopamine replacement therapy in Parkinson's disease
    Maier, Franziska
    Merkl, Josuah
    Ellereit, Anna L.
    Lewis, Catharine J.
    Eggers, Carsten
    Pedrosa, David J.
    Kalbe, Elke
    Kuhn, Jens
    Meyer, Thomas D.
    Zurowski, Mateusz
    Timmermann, Lars
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (04) : 421 - 427
  • [42] The effect of dopamine replacement therapy on cortical structure in Parkinson's disease
    Wu, Chenqing
    Wu, Haoting
    Zhou, Cheng
    Guo, Tao
    Guan, Xiaojun
    Cao, Zhengye
    Wu, Jingjing
    Liu, Xiaocao
    Chen, Jingwen
    Wen, Jiaqi
    Qin, Jianmei
    Tan, Sijia
    Duanmu, Xiaojie
    Gu, Luyan
    Song, Zhe
    Zhang, Baorong
    Huang, Peiyu
    Xu, Xiaojun
    Zhang, Minming
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (04)
  • [43] Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease
    Seemiller, Joseph
    Morrow, Christopher
    Hinkle, Jared T.
    Perepezko, Kate
    Kamath, Vidyulata
    Pontone, Gregory M.
    Mills, Kelly A.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (05): : 534 - 542
  • [44] Impact of Dopamine Replacement Therapy on Shame in Parkinson's Disease Patients
    Chiuve, S. Catalano
    Benis, D.
    Zulet, A.
    Krack, P.
    Fleury, V.
    MOVEMENT DISORDERS, 2023, 38 : S183 - S183
  • [45] Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson?s Disease?
    von Linstow, Christian U.
    DeLano-Taylor, Merritt
    Kordower, Jeffrey H.
    Brundin, Patrik
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (02) : 405 - 411
  • [46] CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease
    Stott, Simon R. W.
    Hayat, Shaista
    Carnwath, Tom
    Garas, Shaady
    Sleeman, Jonathan P.
    Barker, Roger A.
    PLOS ONE, 2017, 12 (02):
  • [47] How Does Tonic Dopamine Level Affect Decision-Making in Dual Tasks in Parkinson's Disease?
    Talarposhti, Maryam Sadeghi
    Hadaeghi, Fatemeh
    Gharibzadeh, Shahriar
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (02) : E65 - E65
  • [48] How does cognition affect reaching in Parkinson's disease?
    Cosgrove, J.
    Picardi, C.
    Smith, S. L.
    Jamieson, S.
    Alty, J. E.
    MOVEMENT DISORDERS, 2016, 31 : S459 - S459
  • [49] How does smoking affect olfaction in Parkinson's disease?
    Moccia, Marcello
    Picillo, Marina
    Erro, Roberto
    Vitale, Carmine
    Amboni, Marianna
    Palladino, Raffaele
    Cioffi, Dante Luigi
    Barone, Paolo
    Pellecchia, Maria Teresa
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) : 215 - 217
  • [50] How does smoking affect olfaction in Parkinson's disease?
    Moccia, M.
    Picillo, M.
    Erro, R.
    Spina, E.
    Vitale, C.
    Amboni, M.
    Falco, F.
    Santangelo, G.
    Pellecchia, M. T.
    Barone, P.
    MOVEMENT DISORDERS, 2014, 29 : S144 - S144